CHEMANOL 2001.SR | SAR 22.84 down -0.86 (-3.63%)
Last updated: 2026-10-29 20:45:50
chemanol.go-globe.dev
عربي

Custom Chemical Solutions

Tailored methanol derivatives for pharmaceutical intermediate synthesis

Industry
Pharmaceutical
Publication Date
January 2026
Client Type
Pharmaceutical Manufacturer

Executive Summary

A pharmaceutical company required ultra-high-purity methanol for API synthesis. Chemanol developed a customized supply solution meeting USP/EP grade specifications.

Challenge

Standard commercial-grade methanol did not meet the purity requirements for pharmaceutical synthesis.

Solution

Chemanol developed a dedicated production run with enhanced purification meeting pharmaceutical grade standards.

Results

99.99%
Purity level achieved
100%
Regulatory compliance (USP/EP)
30%
Cost reduction vs. imported grades
12 Months
Supply agreement duration

Technical Specifications

Product Grade Pharmaceutical USP/EP
Purity ≥99.9% w/w
Water Content ≤0.05%
Residual Solvents Meets ICH Q3C

Conclusion

The client now sources all pharmaceutical-grade methanol from Chemanol under a long-term supply agreement.